|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2118 Batch: A211811
Anti-mouse IL-6-InVivo [MP5-20F3] can reacts with mouse IL-6 (interleukin-6) which is a 21-28 kDa cytokine that is expressed by many cell types, including T lymphocytes, B lymphocytes, monocytes, fibroblasts, and endothelial cells. Anti-mouse IL-6-InVivo has been shown to neutralize the bioactivity of natural or recombinant IL-6.
| Formulation | PBS Buffer, PH 7.4 |
|---|---|
| Clone | MP5-20F3 |
| Immunogen | Recombinant mouse IL-6 |
| Isotype | Rat IgG1, κ |
| Application | in vivo IL-6 neutralization |
| Source | CHO |
| Murine Pathogen Screening Panel | all targets tested yielded Negative Results: Theiler’s Murine Encephalomyelitis Virus, Ectromelia (Mousepox) Virus, Hantavirus, Polyomavirus, Sendai Virus, Mycoplasma pulmonis, Pneumonia Virus of Mice, K Virus, Mouse Parvovirus, Mouse Hepatitis Virus, Mouse Norovirus, Mouse Minute Virus, Mouse Cytomegalovirus, Mouse Adenovirus, Lactate Dehydrogenase-Elevating Virus, Reovirus Panel, Lymphocytic Choriomeningitis Virus, Mouse Rotavirus. |
| Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles. |
| Shipping | Shipped under low temperature conditions |
| Sterility | 0.2 μM filtered |
| Purity | 99% |
| Protein concentration | 4.70 mg/ml |
| Endotoxin Level | <1EU/mg |

| Targeting RPE Senescence Via Suppressing IL-6/IL-6R Signaling for Treating Retinal Degenerative Diseases [ Investigative Ophthalmology & Visual Science, September 2025, Vol.66, 44] | PubMed: 40970669 |
| Targeting RPE Senescence Via Suppressing IL-6/IL-6R Signaling for Treating Retinal Degenerative Diseases [ Investigative Ophthalmology & Visual Science, September 19, 2025, 66(12):44] | PubMed: 40970669 |
| Iron overload in CD11c+ myeloid cells exacerbates acetaminophen hepatotoxicity [ Communications Biology, October 21, 2025, 8(1):1488] | PubMed: 41120657 |
| Calcitonin receptor downregulation and exercise-conditioned blood enable systemic muscle stem cell proliferation [ Nature Communications, November 26, 2025, 16(1):10576] | PubMed: 41298450 |
| Oncolytic virus-induced IL-1β+ monocyte-IL-6+ CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer [ Journal for Immunotherapy of Cancer, November 1, 2025, 13(11):e013175] | PubMed: 41253490 |
| SR-717, a Non-Nucleotide STING Agonist, Displayed Anti-Radiation Activity in a IL-6 Dependent Manner [ The FASEB Journal, May 31, 2025, 39(11):e70644] | PubMed: 40448435 |
| Targeting CD177: A Novel Therapeutic Strategy for NLRP3-Associated Autoinflammatory Diseases [ International Journal of Molecular Sciences, March 20, 2026, 27(6):2841] | PubMed: 41898699 |
| Disruption of the Na+/K+-ATPase-purinergic P2X7 receptor complex in microglia promotes stress-induced anxiety [ Immunity, March 1, 2024, 57(3):495-512.e11] | PubMed: 38395698 |
| The increase of long noncoding RNA Fendrr in hepatocytes contributes to liver fibrosis by promoting IL-6 production [ The Journal of Biological Chemistry, June 1, 2024, 300(6):107376] | PubMed: 38762176 |
| Macrophage STING signaling promotes fibrosis in benign airway stenosis via an IL6-STAT3 pathway [ Nature Communications, January 3, 2025, 16(1):289] | PubMed: 39753529 |
人間や獣医の診断であるか治療的な使用のためにでない。